Malta - Inggris - Medicines Authority

stada arzneimittel ag stadastraße 2-18, 61118 bad vilbel, germany - hard capsule - dabigatran etexilate 75 mg - antithrombotic agents

Malta - Inggris - Medicines Authority

stada arzneimittel ag stadastraße 2-18, 61118 bad vilbel, germany - hard capsule - dabigatran etexilate 110 mg - antithrombotic agents

Malta - Inggris - Medicines Authority

stada arzneimittel ag stadastraße 2-18, 61118 bad vilbel, germany - hard capsule - dabigatran etexilate 150 mg - antithrombotic agents

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - betaine 180 g - powder for oral solution - 1 g - active: betaine 180 g - indicated as an adjunct in the treatment of homocystinuria. indicated to decrease elevated homocysteine blood levels in patients of all age groups with: 1. cystathionine beta-synthase (cbs deficiency) type homocystinuria, or 2. 5,10-methylenetetrahydrofolate reductase deficiency (mthfr deficiency), or 3. cobalamin cofactor metabolism defect (cbl defect) type of homocystinuria. indicated to increase methionine and s-adenosylmethionine blood levels in patients with 5,10-methylenetetrahydrofolate reductase deficiency (mthfr deficiency) and cobalamin cofactor metabolism defect (cbl defect) type of homocystinuria.

Israel - Inggris - Ministry of Health

medison pharma ltd - betaine anhydrous - powder for solution - betaine anhydrous 1 g/g - betaine - treatment of homocystinuria.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

generic partners pty ltd - candesartan cilexetil; hydrochlorothiazide -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - olanzapine benzoate -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - olanzapine -

Uni Eropa - Inggris - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv)

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

stada arzneimittel ag - enalapril maleate - tablets - 2.5 milligram